Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vetnostrum Animal Health CoTPE:6936 +1.09%68 EV-to-EBITDA is 7.07 as of Aug. 20, 2026, which is 33% below its 10-year median of 10.59. GuruFocus rates TPE:6936 with a GF Score™ of 68/100 and a GF Value™ of NT$39.86 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 1,646 Consumer Packaged Goods companies, Vetnostrum Animal Health Co ranks better than 65.31% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vetnostrum Animal Health Co's enterprise value is NT$1,925 Mil.
Vetnostrum Animal Health Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$272 Mil. Therefore, Vetnostrum Animal Health Co's EV-to-EBITDA for today is 7.07.
The historical rank and industry rank for Vetnostrum Animal Health Co's EV-to-EBITDA or its related term are showing as below:
TPE:6936'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.91 Med: 10.59 Max: 48.17
Current: 7.07
During the past 8 years, the highest EV-to-EBITDA of Vetnostrum Animal Health Co was 48.17. The lowest was 6.91. And the median was 10.59.
TPE:6936's EV-to-EBITDA is ranked better than 65.31% of 1646
companies
in the Consumer Packaged Goods industry
Industry Median: 9.055
vs TPE:6936: 7.07
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Vetnostrum Animal Health Co (TPE:6936) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Vetnostrum Animal Health Co's PE Ratio (TTM) for today is calculated as:
Vetnostrum Animal Health Co's share price for today is NT$32.45.
Vetnostrum Animal Health Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2.230.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Farm Products subindustry, Vetnostrum Animal Health Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vetnostrum Animal Health Co EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Vetnostrum Animal Health Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Vetnostrum Animal Health Co's EV-to-EBITDA falls into.
Vetnostrum Animal Health Co's current Enterprise Value is NT$1,925 Mil.
Vetnostrum Animal Health Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$272 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vetnostrum Animal Health Co (TPE:6936) has a EV-to-EBITDA of 7.07 as of Aug. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Vetnostrum Animal Health Co. This is 33% below median its historical median of 10.59. Over the past decade, Vetnostrum Animal Health Co's EV-to-EBITDA has ranged from 6.91 to 48.17. According to the industry distribution chart, Vetnostrum Animal Health Co ranks #571 out of 1646 companies in the Consumer Packaged Goods industry, placing it in the top 34.7%.
Is Vetnostrum Animal Health Co's EV-to-EBITDA too high?
Vetnostrum Animal Health Co's current EV-to-EBITDA of 7.07 is 33% below median its 10-year median of 10.59. Over the past 10 years, this metric has ranged from a low of 6.91 to a high of 48.17. The Consumer Packaged Goods industry median EV-to-EBITDA is 9.06. Vetnostrum Animal Health Co's value of 7.07 is 21.9% below this industry median. Based on the distribution chart, Vetnostrum Animal Health Co ranks #571 out of 1646 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Vetnostrum Animal Health Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vetnostrum Animal Health Co's EV-to-EBITDA compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Vetnostrum Animal Health Co ranks #571 out of 1646 companies for EV-to-EBITDA. This puts Vetnostrum Animal Health Co in the upper half of its industry. The industry median EV-to-EBITDA is 9.06. Vetnostrum Animal Health Co's value of 7.07 is 21.9% below this benchmark. Historically, Vetnostrum Animal Health Co's own EV-to-EBITDA has ranged from 6.91 to 48.17 over the past decade. While the company's 10-year median is 10.59 vs. the industry median of 9.06, Vetnostrum Animal Health Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.06, based on 1,646 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vetnostrum Animal Health Co's current EV-to-EBITDA of 7.07 is 21.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Vetnostrum Animal Health Co. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vetnostrum Animal Health Co's current EV-to-EBITDA is 7.07, which is 33% below median its own 10-year median of 10.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vetnostrum Animal Health Co stock overvalued right now?
Based on GuruFocus' analysis, Vetnostrum Animal Health Co (TPE:6936) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$39.86, compared to a current price of NT$32.45 — trading 18.6% below its estimated fair value. The current EV-to-EBITDA is 7.07, which is 33% below median its 10-year median of 10.59 and 21.9% below the Consumer Packaged Goods industry median of 9.06. Vetnostrum Animal Health Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Vetnostrum Animal Health Co (TPE:6936), the current EV-to-EBITDA is 7.07 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vetnostrum Animal Health Co (TPE:6936) Overvalued in 2026?
Based on GuruFocus' analysis, Vetnostrum Animal Health Co stock appears to be undervalued.
The current stock price of NT$32.45 is trading 18.6% below its estimated GF Value™ of NT$39.86.
GuruFocus considers Vetnostrum Animal Health Co to be Modestly Undervalued.
Key valuation signals for TPE:6936:
EV-to-EBITDA: 7.07 (33% below median its 10-year median of 10.59)
GF Value™: NT$39.86 vs. price of NT$32.45 (18.6% below fair value)
Industry Position: 21.9% below the Consumer Packaged Goods median (#571 of 1646)
No single metric tells the full story. See the TPE:6936 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vetnostrum Animal Health Co Ltd is mainly engaged in importing, manufacturing, and selling pharmaceuticals and nutrition supplements for animals, feed additives, and feed. It derives a majority of its revenue from the sale of animal pharmaceuticals, medicated feed additives, and feeds and the rendering of drug testing services. Geographically, the company derives maximum revenue from Taiwan, followed by the USA, Malaysia, and other countries.
68GF Score
Get the complete analysis for TPE:6936
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6936 has been successfully added to your 
